Related Experiment Videos
HIV-1 associated cognitive/motor complex in an injecting drug user
J Maxwell1, V Egan, A Chiswick
1Infectious Diseases Unit, King's Cross Hospital, Dundee, Scotland, UK.
AIDS Care
|January 1, 1991
Summary
Diagnosing AIDS dementia complex/HIV-1 associated cognitive/motor complex (ADC/HACC) in drug users is challenging but possible with serial testing. This study highlights the clinical and social impacts of ADC/HACC on patient care.
Area of Science:
- Neuroscience
- Infectious Diseases
- Psychiatry
Background:
- The clinical and social consequences of AIDS dementia complex/HIV-1 associated cognitive/motor complex (ADC/HACC) in drug users remain under-documented.
- Patients with premorbid personality disorder and intercurrent drug use present unique diagnostic challenges for ADC/HACC.
Observation:
- Prospective serial neuropsychological, neuroradiological, and neurophysiological measurements are valuable for diagnosing ADC/HACC.
- Psychosocial issues related to ADC/HACC impact community care and hospitalization decisions.
Findings:
- Serial assessments effectively aid in the diagnosis of ADC/HACC in complex patient populations.
- The study demonstrates the utility of a multimodal assessment approach for identifying cognitive and motor impairments in HIV-1 infected drug users.
Implications:
- Findings inform clinical practice regarding the diagnosis and management of ADC/HACC in vulnerable populations.
- Understanding the psychosocial impact is crucial for developing effective community care strategies.
- The relevance of mental health legislation for drug users with ADC/HACC requires consideration.